{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:53:17Z","timestamp":1793407997495,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","award":["EmergenceRecherche2024"],"award-info":[{"award-number":["EmergenceRecherche2024"]}],"id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union-NextGenerationEU","award":["BG-RRP-2.004-0009-C02"],"award-info":[{"award-number":["BG-RRP-2.004-0009-C02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06213-1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:16:11Z","timestamp":1776827771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumour cell-intrinsic complement C1r and C1s regulate cancer cell fitness and shape the immune microenvironment in triple-negative breast cancer"],"prefix":"10.1007","volume":"83","author":[{"given":"Andrea","family":"Minery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Radanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Segarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Peliconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaeddine","family":"Redissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Boudhabhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0324","authenticated-orcid":false,"given":"Lubka T.","family":"Roumenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"6213_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E et al (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31(4):1154\u201362. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"key":"6213_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071102","author":"E Carvalho","year":"2025","unstructured":"Carvalho E, Canberk S, Schmitt F, Vale N (2025) Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17071102","journal-title":"Cancers (Basel)"},{"issue":"8","key":"6213_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN et al (2024) Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer 24(8):554\u201377. https:\/\/doi.org\/10.1038\/s41568-024-00714-6","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"6213_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH (2019) Context-dependent roles of complement in cancer. Nat Rev Cancer 19(12):698\u2013715. https:\/\/doi.org\/10.1038\/s41568-019-0210-0","journal-title":"Nat Rev Cancer"},{"key":"6213_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101950","volume":"78","author":"MR Artero","year":"2025","unstructured":"Artero MR, Minery A, Nedelcev L, Radanova M, Roumenina LT (2025) Complement and the hallmarks of cancer. Semin Immunol 78:101950. https:\/\/doi.org\/10.1016\/j.smim.2025.101950","journal-title":"Semin Immunol"},{"key":"6213_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antib10010002","author":"FNM Akhir","year":"2021","unstructured":"Akhir FNM, Noor MHM, Leong KWK, Nabizadeh JA, Manthey HD, Sonderegger SE et al (2021) An immunoregulatory role for complement receptors in murine models of breast cancer. Antibodies (Basel). https:\/\/doi.org\/10.3390\/antib10010002","journal-title":"Antibodies (Basel)"},{"issue":"9","key":"6213_CR7","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26137","volume":"2","author":"S Bandini","year":"2013","unstructured":"Bandini S, Claudia C, Marco M, Elena Q, Maddalena A, Stefania L et al (2013) Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2\/neu transgenic mice. Oncoimmunology 2(9):e26137. https:\/\/doi.org\/10.4161\/onci.26137","journal-title":"Oncoimmunology"},{"issue":"12","key":"6213_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1253653","volume":"5","author":"S Bandini","year":"2016","unstructured":"Bandini S, Marco M, Albana H, Stefania L, Laura C, Amanda B et al (2016) The non-inflammatory role of C1q during Her2\/neu-driven mammary carcinogenesis. Oncoimmunology 5(12):e1253653. https:\/\/doi.org\/10.1080\/2162402X.2016.1253653","journal-title":"Oncoimmunology"},{"issue":"1","key":"6213_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48637-y","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Poire A, Jeong KJ, Zhang D, Ozmen TY, Chen G et al (2024) C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer. Nat Commun 15(1):4485. https:\/\/doi.org\/10.1038\/s41467-024-48637-y","journal-title":"Nat Commun"},{"issue":"8","key":"6213_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04028-5","volume":"12","author":"B Ou","year":"2021","unstructured":"Ou B, Liu Y, Yang X, Xu X, Yan Y, Zhang J (2021) C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1. Cell Death Dis 12(8):737. https:\/\/doi.org\/10.1038\/s41419-021-04028-5","journal-title":"Cell Death Dis"},{"issue":"1","key":"6213_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1515-2","volume":"39","author":"C Shu","year":"2020","unstructured":"Shu C, Zha H, Long H, Wang X, Yang F, Gao J et al (2020) C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts. J Exp Clin Cancer Res 39(1):11. https:\/\/doi.org\/10.1186\/s13046-019-1515-2","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"6213_CR12","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-14-0157","volume":"74","author":"SK Vadrevu","year":"2014","unstructured":"Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L et al (2014) Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res 74(13):3454\u201365. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0157","journal-title":"Cancer Res"},{"key":"6213_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101976","volume":"79","author":"M Revel","year":"2025","unstructured":"Revel M, Merle NS (2025) Local and cell-intrinsic complement: the new player in cancer progression. Semin Immunol 79:101976. https:\/\/doi.org\/10.1016\/j.smim.2025.101976","journal-title":"Semin Immunol"},{"issue":"7","key":"6213_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","volume":"19","author":"EE West","year":"2023","unstructured":"West EE, Kemper C (2023) Complosome \u2014 the intracellular complement system. Nat Rev Nephrol 19(7):426\u2013439. https:\/\/doi.org\/10.1038\/s41581-023-00704-1","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"6213_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-20-0532","volume":"9","author":"MV Daugan","year":"2021","unstructured":"Daugan MV, Revel M, Russick J, Dragon-Durey MA, Gaboriaud C, Robe-Rybkine T et al (2021) Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of noncanonical functions of C1s. Cancer Immunol Res 9(8):891\u2013908. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0532","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"6213_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1158\/2326-6066.CIR-20-0787","volume":"9","author":"MV Daugan","year":"2021","unstructured":"Daugan MV, Revel M, Thouenon R, Dragon-Durey MA, Robe-Rybkine T, Torset C et al (2021) Intracellular factor H drives tumor progression independently of the complement cascade. Cancer Immunol Res 9(8):909\u201325. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0787","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"6213_CR17","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.4251\/wjgo.v16.i6.2646","volume":"16","author":"YJ Du","year":"2024","unstructured":"Du YJ, Jiang Y, Hou YM, Shi YB (2024) Complement factor I knockdown inhibits colon cancer development by affecting Wnt\/beta-catenin\/c-Myc signaling pathway and glycolysis. World J Gastrointest Oncol 16(6):2646\u20132662. https:\/\/doi.org\/10.4251\/wjgo.v16.i6.2646","journal-title":"World J Gastrointest Oncol"},{"key":"6213_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2024.02.003","volume":"269","author":"A Felberg","year":"2024","unstructured":"Felberg A, Bienkowski M, Stokowy T, Myszczynski K, Polakiewicz Z, Kitowska K et al (2024) Elevated expression of complement factor I in lung cancer cells associates with shorter survival-potentially via non-canonical mechanism. Transl Res 269:1\u201313. https:\/\/doi.org\/10.1016\/j.trsl.2024.02.003","journal-title":"Transl Res"},{"issue":"Pt 3","key":"6213_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113573","volume":"143","author":"L Gao","year":"2024","unstructured":"Gao L, Jing X, Hua Q, Li Z, Lei P, Song P et al (2024) Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation. Int Immunopharmacol 143(Pt 3):113573. https:\/\/doi.org\/10.1016\/j.intimp.2024.113573","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"6213_CR20","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0915","volume":"19","author":"R Ge","year":"2024","unstructured":"Ge R, Luan Z, Guo T, Xia S, Ye J, Xu J (2024) The expression and biological role of complement C1s in esophageal squamous cell carcinoma. Open Life Sci 19(1):20220915. https:\/\/doi.org\/10.1515\/biol-2022-0915","journal-title":"Open Life Sci"},{"issue":"11","key":"6213_CR21","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/mc.23806","volume":"63","author":"Y Ma","year":"2024","unstructured":"Ma Y, Wang Y, Tuo P, Meng Z, Jiang B, Yuan Y et al (2024) Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF-1alpha-regulated glycolysis. Mol Carcinog 63(11):2237\u20132253. https:\/\/doi.org\/10.1002\/mc.23806","journal-title":"Mol Carcinog"},{"issue":"1","key":"6213_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64088-3","volume":"14","author":"L Nissinen","year":"2024","unstructured":"Nissinen L, Riihil\u00e4 P, Viiklepp K, Rajagopal V, Storek MJ, K\u00e4h\u00e4ri V-M (2024) C1s targeting antibodies inhibit the growth of cutaneous squamous carcinoma cells. Sci Rep 14(1):13465. https:\/\/doi.org\/10.1038\/s41598-024-64088-3","journal-title":"Sci Rep"},{"key":"6213_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-026-09807-4","author":"M Rezola Artero","year":"2026","unstructured":"Rezola Artero M, Minery A, Revel M, Armento A, Jarboui MA, Boudhabhay I et al (2026) Intracellular complement Factor H promotes tumor progression through modulation of cell cycle and actin cytoskeleton. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-026-09807-4","journal-title":"Commun Biol"},{"issue":"5","key":"6213_CR24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ajpath.2017.01.006","volume":"187","author":"P Riihil\u00e4","year":"2017","unstructured":"Riihil\u00e4 P, Nissinen L, Farshchian M, Kallajoki M, Kivisaari A, Meri S et al (2017) Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma. Am J Pathol 187(5):1186\u201397. https:\/\/doi.org\/10.1016\/j.ajpath.2017.01.006","journal-title":"Am J Pathol"},{"key":"6213_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143550","author":"P Riihil\u00e4","year":"2019","unstructured":"Riihil\u00e4 P, Nissinen L, Knuutila J, Rahmati Nezhad P, Viiklepp K, K\u00e4h\u00e4ri V-M (2019) Complement System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20143550","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6213_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/bjd.18095","volume":"182","author":"P Riihila","year":"2020","unstructured":"Riihila P, Viiklepp K, Nissinen L, Farshchian M, Kallajoki M, Kivisaari A et al (2020) Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma. Br J Dermatol 182(3):658\u201370. https:\/\/doi.org\/10.1111\/bjd.18095","journal-title":"Br J Dermatol"},{"key":"6213_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-026-00606-4","author":"M Salmela","year":"2026","unstructured":"Salmela M, Nissinen L, Rappu P, Viiklepp K, Ojalill M, Heino J et al (2026) C1s protects cutaneous squamous carcinoma cells from TRAIL-induced apoptosis. Oncogenesis. https:\/\/doi.org\/10.1038\/s41389-026-00606-4","journal-title":"Oncogenesis"},{"issue":"4","key":"6213_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13402-021-00614-z","volume":"44","author":"R Shimazaki","year":"2021","unstructured":"Shimazaki R, Takano S, Satoh M, Takada M, Miyahara Y, Sasaki K et al (2021) Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Cell Oncol 44(4):937\u201350. https:\/\/doi.org\/10.1007\/s13402-021-00614-z","journal-title":"Cell Oncol"},{"issue":"1","key":"6213_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1731135","volume":"9","author":"KI Smolag","year":"2020","unstructured":"Smolag KI, Mueni CM, Leandersson K, Jirstrom K, Hagerling C, Morgelin M et al (2020) Complement inhibitor factor H expressed by breast cancer cells differentiates CD14(+) human monocytes into immunosuppressive macrophages. Oncoimmunology 9(1):1731135. https:\/\/doi.org\/10.1080\/2162402X.2020.1731135","journal-title":"Oncoimmunology"},{"key":"6213_CR30","doi-asserted-by":"crossref","unstructured":"Suzuki REI, Takagi T, Sugimoto M, Sato Y, Irie H, Yomogida Y, et al. (2022) Intracellular C3 Modulates EMT via the Akt\/Smad Pathway in Pancreatic Cancer Cells. Anticancer Research. 42(12):5743.\u00a0https:\/\/doi.org\/10.21873\/anticanres.16081.","DOI":"10.21873\/anticanres.16081"},{"issue":"4","key":"6213_CR31","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2904138","volume":"29","author":"M Tang","year":"2024","unstructured":"Tang M, Zhao S, Ren L, Li Q, Li L, Wang C et al (2024) Tumor cell-derived complement component C1r acts as a prognostic biomarker and promotes esophageal squamous cell carcinoma progression. Front Biosci-Landmark Ed 29(4):138. https:\/\/doi.org\/10.31083\/j.fbl2904138","journal-title":"Front Biosci-Landmark Ed"},{"issue":"5","key":"6213_CR32","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jid.2021.10.008","volume":"142","author":"K Viiklepp","year":"2022","unstructured":"Viiklepp K, Nissinen L, Ojalill M, Riihil\u00e4 P, Kallajoki M, Meri S et al (2022) C1r upregulates production of matrix metalloproteinase-13 and promotes invasion of cutaneous squamous cell carcinoma. J Invest Dermatol 142(5):1478\u201388.e9. https:\/\/doi.org\/10.1016\/j.jid.2021.10.008","journal-title":"J Invest Dermatol"},{"issue":"6","key":"6213_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05869-y","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Hao Y, Chen J, Ding P, Lv X, Zhou D et al (2023) Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A\/HDAC1\/2 complex in non-small cell lung cancer. Cell Death Dis 14(6):351. https:\/\/doi.org\/10.1038\/s41419-023-05869-y","journal-title":"Cell Death Dis"},{"issue":"6","key":"6213_CR34","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.14107","volume":"26","author":"SY Park","year":"2023","unstructured":"Park SY, Eum DY, Jin Y, Lee CY, Shim JW, Choi SH et al (2023) Downregulation of complement factor H attenuates the stemness of MDA\u2011MB\u2011231 breast cancer cells via modulation of the ERK and p38 signaling pathways. Oncol Lett 26(6):521. https:\/\/doi.org\/10.3892\/ol.2023.14107","journal-title":"Oncol Lett"},{"issue":"2","key":"6213_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41416-025-03260-6","volume":"134","author":"T Borisov","year":"2026","unstructured":"Borisov T, Metodiev D, Ferdinandov D, Roumenina LT (2026) Complement system in tumor growth and metastases. Br J Cancer 134(2):185\u2013194. https:\/\/doi.org\/10.1038\/s41416-025-03260-6","journal-title":"Br J Cancer"},{"issue":"10","key":"6213_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350820","volume":"54","author":"NS Merle","year":"2024","unstructured":"Merle NS, Roumenina LT (2024) The complement system as a target in cancer immunotherapy. Eur J Immunol 54(10):2350820. https:\/\/doi.org\/10.1002\/eji.202350820","journal-title":"Eur J Immunol"},{"key":"6213_CR37","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1200\/CCI.19.00119","volume":"4","author":"M Ramos","year":"2020","unstructured":"Ramos M, Geistlinger L, Oh S, Schiffer L, Azhar R, Kodali H et al (2020) Multiomic integration of public oncology databases in Bioconductor. JCO Clin Cancer Inform 4:958\u201371. https:\/\/doi.org\/10.1200\/CCI.19.00119","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"6213_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5","journal-title":"Genome Biol"},{"issue":"11","key":"6213_CR39","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020107333","volume":"40","author":"B Pal","year":"2021","unstructured":"Pal B, Chen Y, Vaillant F, Capaldo BD, Joyce R, Song X et al (2021) A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. EMBO J 40(11):e107333. https:\/\/doi.org\/10.15252\/embj.2020107333","journal-title":"EMBO J"},{"issue":"5","key":"6213_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"issue":"6","key":"6213_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1(6):417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004","journal-title":"Cell Syst"},{"issue":"1","key":"6213_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43435-w","volume":"13","author":"F Rivest","year":"2023","unstructured":"Rivest F, Eroglu D, Pelz B, Kowal J, Kehren A, Navikas V et al (2023) Fully automated sequential immunofluorescence (seqIF) for hyperplex spatial proteomics. Sci Rep 13(1):16994. https:\/\/doi.org\/10.1038\/s41598-023-43435-w","journal-title":"Sci Rep"},{"key":"6213_CR43","doi-asserted-by":"crossref","unstructured":"Boudhabhay I, Artero MR, Vasilev V, Redissi A, Peliconi J, Majdi A et al (2025) In situ Complementomics enables spatial complement activation profiling and identification of therapeutic targets across human tissues. preprint, ResearchSquare, under review","DOI":"10.21203\/rs.3.rs-7784747\/v1"},{"key":"6213_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09303-5","author":"J Heide","year":"2025","unstructured":"Heide J, Bilecz AJ, Patnaik S, Allega MF, Donle L, Yang K et al (2025) NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09303-5","journal-title":"Nature"},{"key":"6213_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","volume":"89","author":"G Arbore","year":"2017","unstructured":"Arbore G, Kemper C, Kolev M (2017) Intracellular complement\u2009\u2013\u2009the complosome\u2009\u2013\u2009in immune cell regulation. Mol Immunol 89:2\u20139. https:\/\/doi.org\/10.1016\/j.molimm.2017.05.012","journal-title":"Mol Immunol"},{"key":"6213_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI188350","author":"T Freiwald","year":"2025","unstructured":"Freiwald T, Afzali B (2025) The secret life of complement: challenges and opportunities in exploring functions of the complosome in disease. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI188350","journal-title":"J Clin Invest"},{"issue":"1","key":"6213_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/imr.13135","volume":"313","author":"BC King","year":"2023","unstructured":"King BC, Blom AM (2023) Intracellular complement: evidence, definitions, controversies, and solutions. Immunol Rev 313(1):104\u2013119. https:\/\/doi.org\/10.1111\/imr.13135","journal-title":"Immunol Rev"},{"issue":"8","key":"6213_CR48","doi-asserted-by":"publisher","first-page":"2350813","DOI":"10.1002\/eji.202350813","volume":"54","author":"BC King","year":"2024","unstructured":"King BC, Blom AM (2024) Intracellular complement and immunometabolism: The advantages of compartmentalization. Eur J Immunol 54(8):2350813. https:\/\/doi.org\/10.1002\/eji.202350813","journal-title":"Eur J Immunol"},{"issue":"10","key":"6213_CR49","doi-asserted-by":"publisher","first-page":"111742","DOI":"10.1016\/j.celrep.2022.111742","volume":"41","author":"AH Janneh","year":"2022","unstructured":"Janneh AH, Kassir MF, Atilgan FC, Lee HG, Sheridan M, Oleinik N et al (2022) Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Rep 41(10):111742. https:\/\/doi.org\/10.1016\/j.celrep.2022.111742","journal-title":"Cell Rep"},{"issue":"1","key":"6213_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"6213_CR51","doi-asserted-by":"crossref","unstructured":"Natalia Kunz JAB, Nicolas S, Merle S, Kartal H, Yamamoto L, Wang M, Taj J, Ma MVK, Kellerhals JLT, Balmer ML, Chandra A, Hess C, Afzali B, West P (2025), Adam G Sowalsky, Claudia Kemper. Cell-autonomous complement C3 activity in prostate epithelial cells suppresses malignant transformation through tonic restrain of the MYC-tumorigenesis program 3135. In: Immunology TJo, editor","DOI":"10.1093\/jimmun\/vkaf283.969"},{"issue":"4","key":"6213_CR52","doi-asserted-by":"publisher","first-page":"100691","DOI":"10.1016\/j.job.2025.100691","volume":"67","author":"TTK Truong","year":"2025","unstructured":"Truong TTK, Fujimoto T, Fujii S, Kurppa KJ, Hasegawa K, Tajiri Y et al (2025) Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation. J Oral Biosci 67(4):100691. https:\/\/doi.org\/10.1016\/j.job.2025.100691","journal-title":"J Oral Biosci"},{"issue":"5","key":"6213_CR53","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/jid.2011.487","volume":"132","author":"JW van Kilsdonk","year":"2012","unstructured":"van Kilsdonk JW, Takahashi N, Weidle U, Burtscher H, Jarry J, Daha MR et al (2012) Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma. J Invest Dermatol 132(5):1462\u20131470. https:\/\/doi.org\/10.1038\/jid.2011.487","journal-title":"J Invest Dermatol"},{"key":"6213_CR54","doi-asserted-by":"publisher","first-page":"1045690","DOI":"10.3389\/fonc.2022.1045690","volume":"12","author":"EK Kleczko","year":"2022","unstructured":"Kleczko EK, Poczobutt JM, Navarro AC, Laskowski J, Johnson AM, Korpela SP et al (2022) Upregulation of complement proteins in lung cancer cells mediates tumor progression. Front Oncol 12:1045690. https:\/\/doi.org\/10.3389\/fonc.2022.1045690","journal-title":"Front Oncol"},{"issue":"3","key":"6213_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","volume":"26","author":"MS Hayden","year":"2014","unstructured":"Hayden MS, Ghosh S (2014) Regulation of NF-kappaB by TNF family cytokines. Semin Immunol 26(3):253\u2013266. https:\/\/doi.org\/10.1016\/j.smim.2014.05.004","journal-title":"Semin Immunol"},{"key":"6213_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-38315-2_1","volume":"1240","author":"W Zhang","year":"2020","unstructured":"Zhang W, Borcherding N, Kolb R (2020) IL-1 signaling in tumor microenvironment. Adv Exp Med Biol 1240:1\u201323. https:\/\/doi.org\/10.1007\/978-3-030-38315-2_1","journal-title":"Adv Exp Med Biol"},{"key":"6213_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00029","volume":"8","author":"A Majoros","year":"2017","unstructured":"Majoros A, Platanitis E, Kernbauer-Holzl E, Rosebrock F, Muller M, Decker T (2017) Canonical and non-canonical aspects of JAK-STAT signaling: lessons from interferons for cytokine responses. Front Immunol 8:29. https:\/\/doi.org\/10.3389\/fimmu.2017.00029","journal-title":"Front Immunol"},{"issue":"1","key":"6213_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli K, Pillarisetty VG, Kim TS (2022) Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther 29(1):10\u201321. https:\/\/doi.org\/10.1038\/s41417-021-00303-x","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"6213_CR59","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677\u2013686. https:\/\/doi.org\/10.1016\/j.it.2004.09.015","journal-title":"Trends Immunol"},{"issue":"11","key":"6213_CR60","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh CH, Lee S, Kwak M, Kim BS, Chung Y (2023) CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med 55(11):2287\u20132299. https:\/\/doi.org\/10.1038\/s12276-023-01105-x","journal-title":"Exp Mol Med"},{"issue":"15","key":"6213_CR61","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK et al (2023) M1\/M2 macrophages and their overlaps - myth or reality? Clin Sci (Lond) 137(15):1067\u201393. https:\/\/doi.org\/10.1042\/CS20220531","journal-title":"Clin Sci (Lond)"},{"key":"6213_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CMAR.S316700","volume":"14","author":"Y Fan","year":"2022","unstructured":"Fan Y, He S (2022) The characteristics of tumor microenvironment in triple negative breast cancer. Cancer Manag Res 14:1\u201317. https:\/\/doi.org\/10.2147\/CMAR.S316700","journal-title":"Cancer Manag Res"},{"issue":"1","key":"6213_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116752","volume":"45","author":"K Mukund","year":"2026","unstructured":"Mukund K, Veraksa D, Frankhouser D, Yang L, Tomsic J, Pillai R et al (2026) Spatially distinct cellular and molecular landscapes define prognosis in triple-negative breast cancer. Cell Rep 45(1):116752. https:\/\/doi.org\/10.1016\/j.celrep.2025.116752","journal-title":"Cell Rep"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06213-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:27:25Z","timestamp":1780626445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06213-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6213"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06213-1","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"LTR reports past consulting fees and research grants in the field of complement from Alexion, Commit Biologics, CSL Behring, Omeros, Erasca, Pierre Fabre and Roche. The remaining authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}